Novo Nordisk A/S

NVO | News | $122.71 -0.03% 0.17% 5M

(0.0% 1d) (-4.5% 1m) (-24.7% 1y) (0.0% 2d) (0.0% 3d) (0.5% 7d) (-100.0% volume)
Earnings Calendar:
Market Cap: $ 421,524,556,880
http://www.novonordisk.com
Sec Filling | Patents | 43258 employees

Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals. The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity. The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

obesity diabetes haemophilia insulin diabetic hormone growth hormone

add to watch list Paper trade email alert is off

Obsidian Energy Ltd

OBE new | $ 0%

Mining, Quarrying, and Oil and ...

(0% volume)
Earnings Calendar:
Market Cap:

Sec Filling | Patents | n/a employees

add to watch list Paper trade email alert is off

South Beach Spirits, Inc.

SBES | $0.0001 233.33% 1K

Real Estate and Rental and Leas...

(0.0% 1d) (9900.0% 1m) (-50.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-99.9% volume)
Earnings Calendar:
Market Cap: $ 618,516

Sec Filling | Patents | 1 employees

add to watch list Paper trade email alert is off